Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Single Use Bioreactors Market by Product (System, Media Bag, Filtration assemblies), Type (Stirred tank, Bubble column), Cell Type (Mammalian, Bacterial, Yeast), Molecule (mAbs, Vaccines), End User (Pharma, Biotech, CROs, CMOs) & Region - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The global single-use bioreactors market is poised for remarkable growth, projected to soar from USD 4.2 billion in 2023 to a substantial USD 10.0 billion by 2028, registering a robust CAGR of 19.0% during the forecast period of 2023 to 2028.
This impressive expansion can be attributed to several key drivers, including the rising adoption of single-use bioreactors among startups and SMEs, the simplified operational processes compared to conventional bioreactors, lower energy and water consumption, and the surging demand in the biologics and biosimilars market.
Furthermore, continuous technological advancements in single-use bioreactors are fueling the market's growth. However, challenges related to extractability and leachability issues, along with regulatory concerns, are posing restraints on the market's progression.
This comprehensive report offers detailed insights into the single-use bioreactors market, estimating its potential growth across various segments and providing a thorough competitive analysis of key players with their recent developments and market strategies.
Bioproduction is expected to account for the largest share for application segment
Based on application, the single-use bioreactors market is segmented into research & development, process development, and bioproduction.
The bioproduction segment accounted for the largest share of the market in 2022 owing to the increasing use of single-use bioreactors in biomanufacturing processes and the increasing demand for single-use bioreactor products in CMOs due to the advantages that they offer such as flexibility and scalability.
The pharmaceutical & biotechnology companies segment accounted for the largest share of the end user segment in the single-use bioreactors market
Based on end users, the single-use bioreactors market is segmented into pharmaceutical & biotechnology companies, CROs & CMOs, and academic & research institutes.
In 2022, the pharmaceutical & biotechnology companies segment accounted for the largest share of the single-use bioreactors market owing to the increasing R&D initiatives by pharmaceutical, biopharmaceutical, and biotechnology companies and a growing biologics & biosimilar production.
Europe is the second largest region in the single-use bioreactors market
After North America, Europe is the second-largest regional pharmaceutical market globally. Increasing adoption of single-use bioreactors by CDMOs and biopharma companies in the region and government support through fundings, investments to support market growth.
Competitive landscape
In-depth assessment of market shares, growth strategies and product offerings of leading players like Sartorius AG (Germany), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany) among others in the single-use bioreactors market.
The report also helps stakeholders understand the pulse of single-use bioreactors market and provides them information on key market drivers, restraints, challenges, and opportunities along with market trends.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 349 |
| Forecast Period | 2021 - 2026 |
| Estimated Market Value (USD) in 2021 | $3.4 billion |
| Forecasted Market Value (USD) by 2026 | $8.8 billion |
| Compound Annual Growth Rate | 20.9% |
| Regions Covered | Global |
Premium Insights
- Growing Biopharmaceutical Industry to Drive Market
- Monoclonal Antibodies Segment Dominated North American Single-Use Bioreactors Market in 2022
- Single-Use Bioreactor Systems to Continue to Dominate Market in 2028
- Pharmaceutical & Biotechnology Companies Accounted for Largest Market Share in 2022
- Asia-Pacific Countries to Register Highest Growth Rate in Single-Use Bioreactors Market from 2023 to 2028
Market Dynamics
Drivers
- Increasing Adoption of Single-Use Bioreactors Among Startups and SMEs
- Reduced Operational Complexity of Single-Use Bioreactors Compared to Conventional Bioreactors
- Lower Energy and Water Consumption
- Growing Biologics and Biosimilars Market
- Technological Advancements in Single-Use Bioreactors
Restraints
- Regulatory Concerns Related to Single-Use Bioreactors
- Issues Related to Leachables and Extractables
Opportunities
- Hybrid Facilities for Sustainable Manufacturing
- Emerging Markets
Challenges
- Standardization of Single-Use Designs
- Disposal of Waste
Industry Trends
Increasing Focus on Single-Use Bioprocessing Capacities and Technological Competitiveness
- Single-Use Bioreactor Capacity Expansions by Major Players
- Increasing Adoption of Single-Use Systems by Contract Development and Manufacturing Organizations
- Automation in Single-Use Bioreactors
Technology Analysis
- Wave-Induced Motion Technology
- Bubble-Column Technology
- Stirred-Tank Technology
- Vertically Perforated Discs
Patent Analysis
Company Profiles
Key Players
- Sartorius Ag
- Danaher Corporation
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Getinge Ab
- Eppendorf Ag
- Entegris, Inc.
- Avantor
- Corning
- Cesco Bioengineering Co., Ltd.
- Kuhner Ag
- Tecnic Bioprocess Equipment Manufacturing
- Pbs Biotech, Inc.
- Satake Multimix Corporation
- G&G Technologies, Inc.
- Abec, Inc.
- Bbi-Biotech GmbH
- Reprocell, Inc.
- Cellexus
- Distek, Inc.
Other Players
- Omnibrx Biotechnologies
- New Horizon Biotechnology Inc.
- Gpc Bio
- Meissner Filtration Products Inc.
- Cell Culture Company, LLC
For more information about this report visit https://www.researchandmarkets.com/r/aim7sw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
